A detailed history of New England Research & Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New England Research & Management, Inc. holds 53,838 shares of BMY stock, worth $3.12 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
53,838
Previous 53,938 0.19%
Holding current value
$3.12 Million
Previous $2.24 Million 24.38%
% of portfolio
1.31%
Previous 1.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$39.66 - $51.75 $3,965 - $5,175
-100 Reduced 0.19%
53,838 $2.79 Million
Q2 2024

Jul 09, 2024

BUY
$40.25 - $52.99 $158,222 - $208,303
3,931 Added 7.86%
53,938 $2.24 Million
Q1 2024

Apr 16, 2024

BUY
$47.98 - $54.4 $223,346 - $253,232
4,655 Added 10.26%
50,007 $2.71 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $99,141 - $118,303
-2,045 Reduced 4.31%
45,352 $2.33 Million
Q3 2023

Oct 10, 2023

SELL
$57.89 - $64.73 $43,706 - $48,871
-755 Reduced 1.57%
47,397 $2.75 Million
Q2 2023

Jul 05, 2023

BUY
$63.71 - $70.74 $344,352 - $382,349
5,405 Added 12.64%
48,152 $3.08 Million
Q1 2023

Apr 06, 2023

BUY
$65.71 - $74.53 $289,124 - $327,932
4,400 Added 11.47%
42,747 $2.96 Million
Q4 2022

Jan 09, 2023

BUY
$68.48 - $81.09 $205,440 - $243,270
3,000 Added 8.49%
38,347 $2.76 Million
Q3 2022

Oct 06, 2022

BUY
$0.13 - $76.84 $1,392 - $823,340
10,715 Added 43.5%
35,347 $2.51 Million
Q2 2022

Jul 20, 2022

SELL
$72.62 - $79.98 $727,071 - $800,759
-10,012 Reduced 28.9%
24,632 $1.9 Million
Q1 2022

Apr 20, 2022

SELL
$61.48 - $73.72 $48,753 - $58,459
-793 Reduced 2.24%
34,644 $2.53 Million
Q4 2021

Jan 05, 2022

SELL
$53.63 - $62.52 $123,349 - $143,796
-2,300 Reduced 6.09%
35,437 $2.21 Million
Q3 2021

Oct 08, 2021

BUY
$59.17 - $69.31 $269,223 - $315,360
4,550 Added 13.71%
37,737 $2.23 Million
Q2 2021

Jul 15, 2021

SELL
$61.91 - $67.42 $21,668 - $23,597
-350 Reduced 1.04%
33,187 $2.22 Million
Q1 2021

Apr 16, 2021

BUY
$59.34 - $66.74 $643,839 - $724,129
10,850 Added 47.82%
33,537 $2.12 Million
Q4 2020

Jan 07, 2021

SELL
$57.74 - $65.43 $697,210 - $790,067
-12,075 Reduced 34.74%
22,687 $1.41 Million
Q3 2020

Oct 08, 2020

SELL
$57.43 - $63.64 $251,256 - $278,425
-4,375 Reduced 11.18%
34,762 $2.1 Million
Q2 2020

Jul 15, 2020

BUY
$54.82 - $64.09 $208,316 - $243,542
3,800 Added 10.75%
39,137 $2.3 Million
Q1 2020

Jun 15, 2020

BUY
$46.4 - $67.43 $199,520 - $289,949
4,300 Added 13.85%
35,337 $1.97 Million
Q4 2019

Jan 14, 2020

SELL
$49.21 - $64.19 $81,196 - $105,913
-1,650 Reduced 5.05%
31,037 $1.99 Million
Q3 2019

Nov 04, 2019

SELL
$42.77 - $50.71 $14,969 - $17,748
-350 Reduced 1.06%
32,687 $1.66 Million
Q2 2019

Jul 09, 2019

SELL
$44.62 - $49.34 $31,234 - $34,538
-700 Reduced 2.07%
33,037 $1.5 Million
Q1 2019

Apr 03, 2019

BUY
$45.12 - $53.8 $465,638 - $555,216
10,320 Added 44.07%
33,737 $1.61 Million
Q4 2018

Jan 11, 2019

BUY
$48.76 - $63.23 $373,014 - $483,709
7,650 Added 48.52%
23,417 $1.22 Million
Q3 2018

Oct 03, 2018

SELL
$55.19 - $62.25 $2,759 - $3,112
-50 Reduced 0.32%
15,767 $979,000
Q2 2018

Jul 05, 2018

SELL
$50.53 - $62.98 $37,897 - $47,235
-750 Reduced 4.53%
15,817 $875,000
Q1 2018

Apr 17, 2018

SELL
$59.92 - $68.98 $365,512 - $420,778
-6,100 Reduced 26.91%
16,567 $1.05 Million
Q4 2017

Jan 09, 2018

SELL
$59.94 - $65.35 $116,883 - $127,432
-1,950 Reduced 7.92%
22,667 $1.39 Million
Q3 2017

Oct 25, 2017

BUY
$55.23 - $63.74 $1.36 Million - $1.57 Million
24,617
24,617 $1.57 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.